Senior Software Engineer – AI Solutions - Developer
About the job
- A bachelor's degree in Computer Science, Software Engineering, IT, or a related field is required.
- Three to five years of experience in software development, technical implementation, backend integration, or solution delivery is required.
- Strong hands-on experience with TypeScript or JavaScript is required.
- Experience with REST APIs, webhooks, JSON, Git, and SQL or databases is required.
- Practical experience with Generative AI, large language models, conversational AI, prompt engineering, or retrieval-augmented generation is required.
- Ability to understand business requirements and convert them into technical workflows and conversational experiences is required.
- Experience troubleshooting API integrations, agent behavior, data flows, and production issues is required.
- Strong communication and stakeholder management skills are required to work directly with clients.
- Ability to work across AI platform configuration, integrations, testing, and custom software development is required.
- Ability to work across multiple client projects and changing requirements is required.
- Design and build AI-powered voice and digital agents using enterprise AI platforms.
- Work directly with clients to understand requirements and translate them into agent personas, prompts, conversation journeys, workflows, and business rules.
- Configure and customize AI agents using platform capabilities, reusable components, and custom code where required.
- Develop and integrate solutions using TypeScript or JavaScript, REST APIs, webhooks, software development kits, and JSON-based interfaces.
- Work with enterprise systems and backend services, including authentication and data integrations.
- Apply prompt engineering, context design, retrieval-augmented generation, tool or function calling, and AI agent concepts to improve agent performance.
- Build and maintain integrations that support client use cases and agent workflows.
- Perform functional testing, troubleshooting, debugging, and optimization across agents, integrations, and backend systems.
- Support client demonstrations, user acceptance testing, deployment, and post-deployment issue resolution.
- Collaborate with Product, Engineering, QA, Solutions, and Client teams throughout the solution delivery lifecycle.
- Identify opportunities to create reusable configurations, components, and integration patterns that improve delivery efficiency across clients.
- Document solution configurations, integrations, technical decisions, and operational requirements.
- Take ownership of assigned technical deliverables and drive them to completion with appropriate guidance from senior technical resources.
- Node.js experience is a plus.
- Experience building or configuring AI agents, chatbots, voicebots, or low-code/no-code solutions is highly desirable.
- Basic understanding of voice and telephony concepts such as SIP, IVR, call routing, and transfers is desirable.
About the company
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Company Size
1-10
Company Stage
Early VC
Total Funding
$4.2M
Headquarters
North Bethesda, Maryland
Founded
2015
Get referred to IBEX
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ibex keeps an open 506(c) offering, signaling active capital formation in 2026.
- The 2022 CD147 patent supports oncology and inflammation licensing conversations.
- Anti-MIF VHH development continues, with animal-model testing already disclosed.
What critics are saying
- Ibex has no disclosed commercial products, leaving revenue dependent on financing.
- The open Regulation D offering implies dilution risk and financing pressure through 2026.
- Without clinical validation, the company risks becoming a perpetual patent shop.
What makes IBEX unique
- North Bethesda-based Ibex Biosciences focuses on antibody, gene-therapy, and stem-cell programs.
- Its 2026 pipeline spans CD147 antibodies, anti-MIF VHHs, and PCBP1 stem-cell methods.
- Ibex still controls early patentable assets, including 2022 CD147 publication.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Performance Bonus
Company News
IBEX has successfully completed a £2 million funding round to advance its mission of using X-ray technology to diagnose osteoporosis early. The company aims to shift from reactive to proactive treatment of this silent disease. With partnerships established with X-ray and mammography OEMs in 2024, IBEX plans to deploy its technology in clinical settings by 2025, demonstrating cost savings for the NHS.
Israeli light control nanotech and smart glass company Gauzy has announced that it has acquired French company Vision Systems, which develops ADAS (Advanced Driver Assistance System) and shading solutions for the aeronautic, land transport, and marine industries.